Retifanlimab

Index terms

Retifanlimab

Sibling codes

XM0550 – Amivantamab
XM0AN7 – Oportuzumab monatox
XM3Q80 – Tislelizumab
XM5Q93 – Sacituzumab govitecan

Foundation entity

Retifanlimab – http://id.who.int/icd/entity/999969687

Part of: XM9ND9: Programmed cell death protein 1/death ligand 1 inhibitors › XM1JG6: Monoclonal antibodies and antibody drug conjugates › XM6WT8: Agents primarily affecting blood constituents or immune system › XM6S30: Medicaments › X: Extension Codes